NCT03934710|CompletedPhase 1ResultsDMCFDA Drug
Mood Effects of Serotonin Agonists Extended
MESA-E
Loading search results
MESA-E
Sponsor study identifier
Secondary identifiers
NIH
interventional
56
1 country
1
Study Start
April 20, 2019
Actual (reported)Primary Completion
June 7, 2021
Actual (reported)Study Completion
June 7, 2021
Actual (reported)In this study we are examining the effects of repeated very low doses of serotonin agonists on mood individuals with negative mood.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 7, 2021
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 20, 2019
Actual (reported)April 29, 2019
Actual (reported)May 2, 2019
Actual (reported)June 7, 2021
Actual (reported)June 7, 2021
Actual (reported)November 29, 2023
Actual (reported)DASS-21
The primary outcome measure is the depression anxiety and stress scale (DASS) 21. This self-report measure contains 21 items and the range of scores for depression is 0-42, anxiety 0-42, and stress 0-42. Our primary outcome measure is total depression scale ratings during session 5, with lower scores indicating lower ratings of depression.
End of session 5, approximately 2 weeks from baseline
Placebo
13ug of serotonin agonist
26ug of serotonin agonist
Drug will be administered in solution form
13ug lysergic acid diethylamide
Matthew Bona
Chicago, Illinois, 60637, United States
Harriet de Wit
University of Chicago
56 participants (actual enrollment reported by the registry).
First Submitted
April 29, 2019
First Posted
May 2, 2019
Study Start
April 20, 2019
Actual (reported)A Safety, Tolerability, and Pharmacokinetic Study of Tucatinib in Healthy Japanese and Caucasian Subjects
26ug lysergic acid diethylamide
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
June 7, 2021
Actual (reported)Study Completion
June 7, 2021
Actual (reported)Last Updated
November 29, 2023
Results First Posted
November 29, 2023
Record last verified: 2023-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: